Previous Close | 0.2500 |
Open | 0.2550 |
Bid | 0.2400 x N/A |
Ask | 0.2500 x N/A |
Day's Range | 0.2400 - 0.2550 |
52 Week Range | 0.2000 - 0.8500 |
Volume | |
Avg. Volume | 19,990 |
Market Cap | 9.58M |
Beta (5Y Monthly) | -0.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1600 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, welcomed Health Canada’s conduct of a Drug Establishment License (DEL) audit. The audit, which aims to expand the Company's Good Manufacturing Practices (GMP) capabilities, follows the recent achievement of GMP certification for HYT
One of the only Canadian firms meeting the stringent specifications of both the German Pharmacopoeia and European Pharmacopoeia for Cannabis FlowerVANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0, "HYTN" or "The Company"), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, is pleased to provide an update on the company’s new strategic goals and
VANCOUVER, British Columbia and LAS VEGAS, March 25, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:NURS)(OTCQB:HYDTF)(FSE:S06) a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is pleased to announce that it has partnered with American Frontline Nurses, a leading advocacy organization that offers programs that improve health outcomes for vulnerable patient populations